Blog

Rahul Gosain: Recap ASCO 23 plenary discussion, importance of MultiD approach, as you get ready for ASCO 24

Photo taken from Oncology Brothers/X

May 28, 2024, 07:58

Rahul Gosain: Recap ASCO 23 plenary discussion, importance of MultiD approach, as you get ready for ASCO 24

Rahul Gosain, Director of Regional Infusion Services at

“GI Series: As you get ready for ASCO 24, Rohit Gosain, MD and I recap ASCO 23 plenary discussion, importance of MultiD approach, and the current landscape of Rectal Cancer with Deb Schrag & Krishan Jethwa

Selective omission of Surgery, XRT, and Chemo is the key.

Full discussion:

Also on the “Oncology Brothers” podcast.”

Source: Rahul Gosain/LinkedIn
.

ASCO 23 ASCO 24 cancer current landscape of rectal cancer Deb Schrag GI Series Krishan Jethwa MultiD approach OncoDaily Oncology Oncology Brothers podcast plenary discussion Rahul Gosain rectal cancer rectal cancer treatment Rohit Gosain MD selective omission of chemo selective omission of surgery selective omission of XRT Wilmot Cancer Institute

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage